Zoetis Balance Sheet
NYSE: ZTSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:03 PM ET · Delayed 15 min
Zoetis financial position
At the end of fiscal 2025, Zoetis reported total assets of $15.49 billion, up 8.8% from a year earlier against total liabilities of $12.07 billion. Shareholders' equity stood at $3.42 billion, or 22.0% of assets. The company held $2.45 billion in cash and equivalents against $9.04 billion of debt, a net debt position of $6.59 billion.
The current ratio (current assets divided by current liabilities) was 3.12, meaning short-term assets cover obligations due within a year. Debt-to-equity was 2.65.
Summary generated from market data by MetaCap's automated system. Methodology
Zoetis balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 2.45B | 1.99B | 2.04B | 3.58B | 3.48B | 3.60B | 1.93B | 1.60B | 1.56B | 727.00M |
| Short-Term Investments | 0 | — | — | — | — | — | 0 | 99.00M | 0 | — |
| Receivables | 1.41B | 1.32B | 1.30B | 1.22B | 1.13B | 1.01B | 1.09B | 1.04B | 998.00M | 913.00M |
| Inventory | 2.46B | 2.31B | 2.56B | 2.35B | 1.92B | 1.63B | 1.41B | 1.39B | 1.43B | 1.50B |
| Total Current Assets | 6.77B | 5.99B | 6.34B | 7.51B | 6.93B | 6.61B | 4.75B | 4.40B | 4.22B | 3.39B |
| Property, Plant & Equipment | 3.69B | 3.39B | 3.20B | 2.75B | 2.42B | 2.20B | 1.94B | 1.66B | 1.44B | 1.38B |
| Goodwill | 2.77B | 2.72B | 2.76B | 2.75B | 2.68B | 2.69B | 2.59B | 2.52B | 1.51B | 1.48B |
| Intangible Assets | 998.00M | 1.13B | 1.34B | 1.38B | 1.47B | 1.71B | 1.89B | 2.05B | 1.27B | 1.23B |
| Total Assets | 15.49B | 14.24B | 14.29B | 14.93B | 13.90B | 13.61B | 11.54B | 10.78B | 8.59B | 7.65B |
| Accounts Payable | 445.00M | 433.00M | 411.00M | 405.00M | 436.00M | 457.00M | 301.00M | 313.00M | 261.00M | 265.00M |
| Short-Term Debt | 0 | 1.35B | 3.00M | 1.35B | 0 | 604.00M | 500.00M | 9.00M | 0 | 0 |
| Total Current Liabilities | 2.17B | 3.41B | 1.89B | 3.17B | 1.80B | 2.17B | 1.81B | 1.22B | 1.09B | 1.12B |
| Long-Term Debt | 9.04B | 5.22B | 6.56B | 6.55B | 6.59B | 6.59B | 5.95B | 6.44B | 4.95B | 4.47B |
| Total Liabilities | 12.07B | 9.47B | 9.29B | 10.52B | 9.36B | 9.84B | 8.84B | 8.59B | 6.80B | 6.15B |
| Shareholders' Equity | 3.42B | 4.77B | 5.00B | 4.41B | 4.54B | 3.77B | 2.71B | 2.19B | 1.77B | 1.49B |
| Retained Earnings | 13.80B | 11.97B | 10.29B | 8.67B | 7.19B | 5.66B | 4.43B | 3.27B | 2.11B | 1.48B |
| Total Debt | 9.04B | 6.57B | 6.57B | 7.90B | 6.59B | 7.20B | 6.45B | 6.45B | 4.95B | 4.47B |
| Net Cash (Debt) | -6.59B | -4.58B | -4.53B | -4.32B | -3.11B | -3.60B | -4.51B | -4.75B | -3.39B | -3.74B |
| Shares Outstanding | 424.93M | 448.47M | 458.37M | 463.81M | 472.57M | 475.32M | 475.53M | 479.56M | 486.13M | 492.86M |
This table shows 10 annual periods of Zoetis's balance sheet, from FY 2025 back to FY 2016, across 19 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow ZTS's reporting calendar. What is a balance sheet?